Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

PATH vs CORZ: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

PATH Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 7–3 Matrix Metrics)

PATH Overall Winner 6-Pillar Tally: PATH 3 – 3 CORZ Matrix Metrics: PATH 7 – 3 CORZ

As of Nov 16, 2026, UiPath, Inc. (PATH) is the stronger overall head-to-head candidate over Core Scientific, Inc. (CORZ) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). PATH carries a Unified Composite Score of 56.8/100 (HOLD) at $13.24 (17.4x Forward P/E, 9.4% operating margin), whereas CORZ carries 40.6/100 (SELL) at $13.47 (16.6x Forward P/E, -2.1% operating margin).

  • Growth vs. Quality Trade-Off: PATH earns the overall head-to-head edge with a stronger Unified Composite Score (56.8/100 HOLD vs. CORZ 40.6/100 SELL) and 0.86β · 30% Vol risk profile, whereas CORZ leads top-line expansion (+187.1% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: PATH is currently in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 48.8); meanwhile CORZ is in a Breakdown options structure phase (RSI 47.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About PATH vs CORZ
PATH NYSE Head-to-Head Winner
UiPath, Inc.
Services-Prepackaged Software
$13.24
-0.19% 1D
Market Cap $6.8B
TTM Revenue $1.72B
Forward P/E 17.4x
Beta / 30D Vol 0.86β · 30% Vol
Unified Composite Score
56.8 / 100 HOLD
Tech 75.0 Fund 66.0 Flow 68.0 Mom 60.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -8.7%) with fading momentum, RSI 49
RSI-14: 48.8 · SMA20: $13.50 · SMA50: $13.38
CORZ NASDAQ
Core Scientific, Inc. Common Stock
Finance Services
$13.47
-7.2% 1D
Market Cap $4.6B
TTM Revenue $592M
Forward P/E 16.6x
Beta / 30D Vol 2.91β · 109% Vol
Unified Composite Score
40.6 / 100 SELL
Tech 15.0 Fund 47.0 Flow 59.0 Mom 64.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 47
RSI-14: 47.0 · SMA20: $13.51 · SMA50: $15.31

6-Pillar Scorecard Institutional Category Breakdown (PATH 3 – 3 CORZ)

Columns: Metric · PATH · CORZ
1. Valuation Multiples CORZ
Forward P/E 17.4x 16.6x
Trailing P/E 19.6x 16.6x
PEG Ratio 0.41x N/M
EV / Revenue 3.7x 13.7x
2. Growth & Scale CORZ
Revenue Growth (YoY) +13.4% +187.1%
Earnings Growth (YoY) N/A +61.2%
TTM Revenue (USD) $1.72B $592M
Market Cap $6.8B $4.6B
3. Profitability & Quality PATH
Gross Margin 82.6% 44.1%
Operating Margin 9.4% -2.1%
Net Profit Margin 21.0% -18.3%
Return on Equity (ROE) 20.0% 0.0%
4. Balance Sheet & Cash Flow PATH
Cash Generation (TTM) $363M -$1.32B
Cash Flow Margin 21.1% N/A
Net Cash / Leverage $528M Net Cash $3.50B Net Debt
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning CORZ
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile 50.3% (11th %ile) 80.6% (28th %ile)
Put/Call OI Skew 0.49x (Call-Skewed) 0.36x (Call-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Distribution ACCUMULATION · Neutral
6. R&D & Supply-Chain Moat PATH
OpEx & R&D Intensity 73.2% of Rev ($1.26B) 46.2% of Rev ($274M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Software - Infrastructure Operator Software - Infrastructure Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: PATH (7) vs CORZ (3)
Institutional Metric PATH CORZ Criterion Row Edge
Market Capitalization
Scale
$6.8B $4.6B Larger Scale PATH
Trailing P/E Ratio
Valuation
19.6x 16.6x Lower Multiple CORZ
Forward P/E Ratio
Valuation
17.4x 16.6x Lower Multiple CORZ
Revenue Growth (YoY)
Growth
+13.4% +187.1% Higher Growth CORZ
Operating Margin (TTM)
Profitability
9.4% -2.1% Higher Margin PATH
Net Profit Margin
Profitability
21.0% -18.3% Higher Margin PATH
Return on Equity (ROE)
Capital Efficiency
20.0% 0.0% Higher ROE PATH
52-Week Range Position
Momentum
38% ($9–$20) 14% ($11–$30) Stronger Trend PATH
Beta / 30D Volatility
Risk Regime
0.86β · 30% Vol 2.91β · 109% Vol Lower Realized Risk PATH
Unified Institutional Score
Composite Signal
56.8 / 100 (HOLD) 40.6 / 100 (SELL) Higher Composite PATH
Trailing 12M Revenue (USD)
Operating Scale
$1.72B $592M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
82.6% 44.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.41x PEG · 3.7x EV/Rev N/M PEG · 13.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$363M ($528M Net Cash) -$1.32B ($3.50B Net Debt) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon PATH +3.11 pp
PATH: +3.07% · CORZ: -0.04%
3M Horizon PATH +13.52 pp
PATH: -14.99% · CORZ: -28.51%
6M Horizon PATH +67.31 pp
PATH: +24.48% · CORZ: -42.83%
1Y Horizon PATH +5.11 pp
PATH: -6.0% · CORZ: -11.11%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period PATH Revenue CORZ Revenue PATH Op. Margin CORZ Op. Margin Margin Leader
FY2020 $340M $60M -153.9% -10.5% CORZ
FY2021 $610M $540M -18.2% 24.2% CORZ
FY2022 $890M $640M -56.1% -329.5% PATH
FY2023 $1.06B $500M -32.9% 1.8% CORZ
FY2024 $1.31B $510M -12.6% -27.8% PATH
FY2025 $1.43B $320M -11.4% -77.0% PATH
FY2026 $1.61B N/A 3.5% N/A PATH

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
PATH BREAKDOWN
54d in phase · OBV DISTRIBUTION
Current IV 50.3%
IV Percentile 11th %ile
Put/Call OI Skew 0.49x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact PATH Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CORZ BREAKDOWN
104d in phase · OBV ACCUMULATION
Current IV 80.6%
IV Percentile 28th %ile
Put/Call OI Skew 0.36x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact CORZ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
PATH Moat Profile Scale & Operating Efficiency Moat
Software - Infrastructure Operator
Competes within the Software - Infrastructure value chain with $6.8B market capitalization and 9.4% operating margin.
OpEx & R&D Reinvestment 73.2% of Rev ($1.26B)
90D Engineering Disclosures 0 Published
CORZ Moat Profile Cyclical / Execution-Driven Positioning
Software - Infrastructure Operator
Competes within the Software - Infrastructure value chain with $4.6B market capitalization and -2.1% operating margin.
OpEx & R&D Reinvestment 46.2% of Rev ($274M)
90D Engineering Disclosures 0 Published

Investor FAQ PATH vs CORZ Key Questions & Quantitative Answers

As of Nov 16, 2026, UiPath, Inc. (PATH) is the stronger overall head-to-head candidate over Core Scientific, Inc. (CORZ) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). PATH carries a Unified Composite Score of 56.8/100 (HOLD) at $13.24 (17.4x Forward P/E, 9.4% operating margin), whereas CORZ carries 40.6/100 (SELL) at $13.47 (16.6x Forward P/E, -2.1% operating margin). Growth vs. Quality Trade-Off: PATH earns the overall head-to-head edge with a stronger Unified Composite Score (56.8/100 HOLD vs. CORZ 40.6/100 SELL) and 0.86β · 30% Vol risk profile, whereas CORZ leads top-line expansion (+187.1% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: PATH is currently in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 48.8); meanwhile CORZ is in a Breakdown options structure phase (RSI 47.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CORZ leads the Growth & Scale pillar: PATH posts +13.4% YoY revenue growth and N/A YoY earnings growth on $1.72B TTM revenue (82.6% gross margin, 9.4% operating margin), compared with CORZ at +187.1% YoY revenue growth and +61.2% YoY earnings growth on $592M TTM revenue (44.1% gross margin, -2.1% operating margin). Across the 7-period historical trajectory (FY2020 to FY2026), PATH cumulative revenue shifted +373.5% while CORZ shifted +433.3%. In operating R&D and SG&A reinvestment, PATH deploys 73.2% of Rev ($1.26B) (0 90-day corporate R&D disclosures) versus 46.2% of Rev ($274M) (0 disclosures) for CORZ.

CORZ screens cheaper on headline valuation multiples. PATH trades at 17.4x Forward P/E, 19.6x Trailing P/E, 0.41x PEG, and 3.7x EV/Revenue (21.1% FCF margin), whereas CORZ trades at 16.6x Forward P/E, 16.6x Trailing P/E, N/M PEG, and 13.7x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PATH (20.0% ROE) versus CORZ (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, PATH carries 50.3% implied volatility (11th %ile, Compressed (<25th %ile)), a 0.49x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (0.86β · 30% Vol realized risk). By comparison, CORZ carries 80.6% implied volatility (28th %ile, Balanced (25th–60th %ile)), a 0.36x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (2.91β · 109% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.